ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,848
Screening encounters
3,213
Diagnostic referrals
620
Outstanding pathways
240

Screening pathway

  1. Screening3,213Encounters
  2. Positive finding1,096Documented findings
  3. Referral620Diagnostic referrals
  4. Follow-up725Diagnostic visits
  5. Outcome380Resolved pathways

Stage totals use different units. Pending pathways: 240. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4111 · EXP-4111Synthetic · Site A

Full participant history through 2026-05-26, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-10-06
  4. · Diagnostic referral · EXP-4111-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Reached
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Diagnosis · Histopathology · No high-grade lesion identified
  11. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-23
  12. · Follow-up disposition · Resolved · EXP-4111-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Screened participants

2848 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4034 · Expanded synthetic participant 4034Site A — Urban Referral Hub
EXP-4035 · Expanded synthetic participant 4035Site B — Peri-Urban Access Programme
EXP-4038 · Expanded synthetic participant 4038Site D — Community Engagement Programme
EXP-4039 · Expanded synthetic participant 4039Site D — Community Engagement Programme
EXP-4041 · Expanded synthetic participant 4041Site B — Peri-Urban Access Programme
EXP-4043 · Expanded synthetic participant 4043Site B — Peri-Urban Access Programme
EXP-4045 · Expanded synthetic participant 4045Site A — Urban Referral Hub
EXP-4046 · Expanded synthetic participant 4046Site A — Urban Referral Hub
EXP-4049 · Expanded synthetic participant 4049Site C — Rural Outreach Programme
EXP-4051 · Expanded synthetic participant 4051Site B — Peri-Urban Access Programme
EXP-4052 · Expanded synthetic participant 4052Site B — Peri-Urban Access Programme
EXP-4053 · Expanded synthetic participant 4053Site E — Resource-Constrained Navigation Programme
EXP-4055 · Expanded synthetic participant 4055Site C — Rural Outreach Programme
EXP-4056 · Expanded synthetic participant 4056Site B — Peri-Urban Access Programme
EXP-4057 · Expanded synthetic participant 4057Site E — Resource-Constrained Navigation Programme
EXP-4059 · Expanded synthetic participant 4059Site E — Resource-Constrained Navigation Programme
EXP-4061 · Expanded synthetic participant 4061Site A — Urban Referral Hub
EXP-4062 · Expanded synthetic participant 4062Site E — Resource-Constrained Navigation Programme
EXP-4064 · Expanded synthetic participant 4064Site A — Urban Referral Hub
EXP-4066 · Expanded synthetic participant 4066Site A — Urban Referral Hub
EXP-4067 · Expanded synthetic participant 4067Site B — Peri-Urban Access Programme
EXP-4068 · Expanded synthetic participant 4068Site A — Urban Referral Hub
EXP-4069 · Expanded synthetic participant 4069Site A — Urban Referral Hub
EXP-4070 · Expanded synthetic participant 4070Site D — Community Engagement Programme
EXP-4072 · Expanded synthetic participant 4072Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1301
HPV DNA
1440
Cytology
472

Navigation activity

Barrier documented
535
Contact attempt
917
Navigation intervention
231
Diagnostic booking
773
Diagnostic visit
725

Documented barriers

Contact difficulty
177
Transport difficulty
165
Appointment coordination
193

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.